I’m with you on this. The sales team in the US has performed extremely well under difficult conditions over the past two years. And from what SR has said they are extremely energised and focused. I think that if hospital/ clinician access continues to improve that they will outperform the excellent growth obtained this last FY.
- Forums
- ASX - By Stock
- Ann: FY22 Results Presentation
I’m with you on this. The sales team in the US has performed...
-
- There are more pages in this discussion • 85 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PNV (ASX) to my watchlist
|
|||||
Last
$2.35 |
Change
0.020(0.86%) |
Mkt cap ! $1.623B |
Open | High | Low | Value | Volume |
$2.27 | $2.37 | $2.27 | $3.035M | 1.301M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
14 | 26580 | $2.35 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$2.37 | 12054 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
14 | 26580 | 2.350 |
6 | 22648 | 2.330 |
2 | 12529 | 2.320 |
3 | 13844 | 2.310 |
2 | 12529 | 2.300 |
Price($) | Vol. | No. |
---|---|---|
2.370 | 12054 | 2 |
2.380 | 28886 | 5 |
2.390 | 26956 | 4 |
2.400 | 24529 | 5 |
2.410 | 11810 | 2 |
Last trade - 16.10pm 09/09/2024 (20 minute delay) ? |
Featured News
PNV (ASX) Chart |